All pages
Jump to navigation
Jump to search
Previous page (Tetracycline hydrochloride indications and usage) | Next page (The Living Guidelines: Initial Clinical Assessment of Patients Presenting with Heart Failure. Polling Results for CLASS I Guidelines)
- The Cancer Council New South Wales
- The Cancer Council Queensland
- The Canon of Medicine
- The Chest X Ray in Cardiovascular Disease
- The China Study
- The Collected Works of C. G. Jung
- The Community Chest of Hong Kong
- The Continua Health Alliance
- The CoreValve US Pivotal Trial
- The Couma-Gen Study Demonstrates that Genotyping in Clinical “Real-Time” is Possible to Predict the Necessary Dose of Warfarin Needed in Individuals
- The Couma-Gen Study did not Demonstrate a Reduction in Out-of-range INRs in Patients with Pharmacogenetic-guided Dosing of Warfarin
- The Cursed Videotape
- The Danish Association of Pharmaconomists
- The Danish College of Pharmacy Practice
- The Diet Smart Plan
- The Discovery of the Unconscious
- The Do This Get That Guide On Investment Casting Foundry
- The Duess Test
- The EKG in Hypercalcemia
- The EKG in Hyperkalemia
- The EKG in Hypocalcemia
- The EKG in Hypokalemia
- The EKG in a Patient with a Pacemaker
- The EKG in a patient with a pacemaker
- The EKG in the Patient Treated with Adenosine
- The EKG in the Patient Treated with Amiodarone
- The EKG in the Patient Treated with Beta Blockers
- The EKG in the Patient Treated with Bretylium
- The EKG in the Patient Treated with Ca Channel Blockers
- The EKG in the Patient Treated with Digitalis
- The EKG in the Patient Treated with Disopyramide
- The EKG in the Patient Treated with Encainide, Flecainide and Propafenone
- The EKG in the Patient Treated with Lidocaine
- The EKG in the Patient Treated with Lithium
- The EKG in the Patient Treated with Phenothiazines
- The EKG in the Patient Treated with Phenytoin
- The EKG in the Patient Treated with Procainamide
- The EKG in the Patient Treated with Quinidine
- The EKG in the Patient Treated with Tocainide
- The EKG in the Patient Treated with Tricyclic Antidepressants
- The EKG in the Patient with a Ventricular Septal Defect (VSD)
- The EKG in the Patient with an Atrial Septal Defect (ASD)
- The EKG in the patient treated with Bretylium
- The EKG in the patient treated with Tocainide
- The EKG in the patient treated with adenosine
- The EKG in the patient treated with amiodarone
- The EKG in the patient treated with beta blockers
- The EKG in the patient treated with bretylium
- The EKG in the patient treated with calcium channel blockers
- The EKG in the patient treated with digitalis
- The EKG in the patient treated with disopyramide
- The EKG in the patient treated with encainide, flecainide and propafenone
- The EKG in the patient treated with lidocaine
- The EKG in the patient treated with lithium
- The EKG in the patient treated with phenothiazines
- The EKG in the patient treated with phenytoin
- The EKG in the patient treated with procainamide
- The EKG in the patient treated with quinidine
- The EKG in the patient treated with tocainide
- The EKG in the patient treated with tricyclic antidepressants
- The EKG of Cardiac Transplantation
- The EKG of Traumatic Heart Disease
- The EKG of cardiac transplantation
- The EVEREST trial suggests MitraClip® for mitral regurgitation is effective
- The Efficacy of XIENCE V Stent over Taxus Stent Decreases with Time: Results from the SPIRIT II study
- The Ego and the Id
- The Electrocardiogram
- The Elephant Man
- The Endocrine Society
- The Environmental Determinants of Diabetes in the Young
- The European Union of the Deaf
- The Female Brain
- The Filatov Institute of Eye Diseases & Tissue Therapy
- The Finger Lakes School of Massage
- The Forsyth Institute
- The Framingham Heart Study
- The Frankenfood Myth
- The Fred Hollows Foundation
- The GENESIS Trial Demonstrates Disappointing Results With Pimecrolimus Eluting Stents
- The GISSI-HF trial suggests long-term treatment with n-3 PUFAs provides moderate clinical benefits for chronic heart failure patients
- The GRACE Risk Score
- The GRACE risk score
- The Genetic Basis of Heart Disease
- The Genographic Project
- The George Foundation
- The George Institute for International Health
- The Global Fund to Fight AIDS, Tuberculosis and Malaria
- The Golden Book of Chemistry Experiments
- The Gothenburg Study of Children with DAMP
- The Grasp of the Phantom
- The Grit
- The Group Selection Squad
- The HACEK Group
- The HACEK group
- The HAMILTON score
- The HAMILTON score for DVT
- The Hacker's Diet
- The Heart in Ankylosing Spondylitis
- The Heart in Antiphospholipid Syndrome
- The Heart in Behçet's disease
- The Heart in Breast Cancer
- The Heart in CNS Tumors
- The Heart in Celiac Disease
- The Heart in Chagas' disease
- The Heart in Crohn's Disease
- The Heart in Degos' Disease
- The Heart in Essential Mixed Cryoglobulinemia
- The Heart in Gastrointestinal, Hepatobilier & Pancreatic Tumors
- The Heart in Grave's Disease (Overactive Thyroid)
- The Heart in Guillain Barre Syndrome
- The Heart in Gynecologic Tumors
- The Heart in Hashimoto's Thyroiditis (Underactive Thyroid)
- The Heart in Head and Neck Tumors
- The Heart in Hodgkin Lymphoma
- The Heart in Insulin Dependent Diabetes Mellitus
- The Heart in Juvenile Rheumatoid Arthritis
- The Heart in Köhlmeier-Degos Disease
- The Heart in Leukemias
- The Heart in Lung Cancers
- The Heart in Lymphomas
- The Heart in Mixed Connective Tissue Disorder
- The Heart in Mixed Connective Tissue Disorders
- The Heart in Multiple Myeloma
- The Heart in Oncologic Disease
- The Heart in Osteosarcomas
- The Heart in Pancreatic Tumors
- The Heart in Peritoneal and Mesothelial Tumors
- The Heart in Polyarteritis Nodosa
- The Heart in Polychondritis
- The Heart in Polymyositis and Dermatomyositis
- The Heart in Primary Myocardial Tumors
- The Heart in Progressive Systemic Sclerosis (Scleroderma)
- The Heart in Psoriasis
- The Heart in Reiter's Syndrome
- The Heart in Rheumatic Fever
- The Heart in Rheumatoid Arthritis
- The Heart in Sarcoidosis
- The Heart in Sjögren’s Syndrome
- The Heart in Skin Cancers
- The Heart in Systemic Lupus Erythematosus (SLE)
- The Heart in Takayasu Arteritis
- The Heart in Temporal Arteritis / Giant Cell Arteritis
- The Heart in The Heart in Head and Neck Tumors
- The Heart in Thyroid and Parathyroid Cancers
- The Heart in Tumors that Originated from Vascular Structure
- The Heart in Ulcerative colitis
- The Heart in Urinary System Tumors
- The Heart in Wegener's Granulomatosis
- The Heart in Wilson's Disease
- The Helsinki Heart Study
- The Heuga Center for Multiple Sclerosis
- The Homelessness Project
- The Hormone Foundation
- The IMPROVE risk score
- The IMPROVE score
- The Imaginary (psychoanalysis)
- The Inner Life of the Cell
- The Instance of the Letter in the Unconscious, or Reason Since Freud
- The Institute for Genomic Research
- The Institute of Living
- The International Journal of Psychiatry
- The International Paleopsychology Project
- The International Pharmacopoeia
- The International Society of Pharmacovigilance
- The Israel Journal of Psychiatry and Related Sciences
- The JUPITER Trial
- The Jimmy Fund
- The Journal of Medical Practice Management
- The Kurtzke Expanded Disability Status Scale (EDSS)
- The Lancet
- The Latency Phase (6-12 years of age)
- The Leaf (AI) Project
- The Learning Center for Deaf Children
- The Left Heart Catheterization
- The Lesion Project
- The Lipodystrophies and Other Rare Disorders of Adipose Tissue
- The Living Guidelines
- The Living Guidelines:UA/NSTEMI Antiplatelet Therapy
- The Living Guidelines: Ancillary Therapy for Patients Undergoing PCI for STEMI Polling Results for CLASS III Guidelines
- The Living Guidelines: Ancillary Therapy for Patients Undergoing PCI for STEMI Polling Results for CLASS I Guidelines
- The Living Guidelines: Ancillary Therapy for Patients Undergoing PCI for STEMI Suggest Revisions to the CLASS III Guidelines
- The Living Guidelines: Ancillary Therapy for Patients Undergoing PCI for STEMI Suggest Revisions to the CLASS I Guidelines
- The Living Guidelines: Ancillary Therapy for Patients Undergoing PCI for STEMI View the Current CLASS III Guidelines
- The Living Guidelines: Ancillary Therapy for Patients Undergoing PCI for STEMI View the Current CLASS I Guidelines
- The Living Guidelines: Antiplatelet Agents/Anticoagulants: Aspirin Polling Results for CLASS IIa Guidelines
- The Living Guidelines: Antiplatelet Agents/Anticoagulants: Aspirin Polling Results for CLASS I Guidelines
- The Living Guidelines: Antiplatelet Agents/Anticoagulants: Aspirin Suggest Revisions to the CLASS IIa Guidelines
- The Living Guidelines: Antiplatelet Agents/Anticoagulants: Aspirin Suggest Revisions to the CLASS I Guidelines
- The Living Guidelines: Antiplatelet Agents/Anticoagulants: Aspirin View the Current CLASS IIa Guidelines
- The Living Guidelines: Antiplatelet Agents/Anticoagulants: Aspirin View the Current CLASS I Guidelines
- The Living Guidelines: Antiplatelet Agents/Anticoagulants: Clopidogrel Polling Results for CLASS IIa Guidelines
- The Living Guidelines: Antiplatelet Agents/Anticoagulants: Clopidogrel Polling Results for CLASS I Guidelines
- The Living Guidelines: Antiplatelet Agents/Anticoagulants: Clopidogrel Suggest Revisions to the CLASS IIa Guidelines
- The Living Guidelines: Antiplatelet Agents/Anticoagulants: Clopidogrel Suggest Revisions to the CLASS I Guidelines
- The Living Guidelines: Antiplatelet Agents/Anticoagulants: Clopidogrel View the Current CLASS IIa Guidelines
- The Living Guidelines: Antiplatelet Agents/Anticoagulants: Clopidogrel View the Current CLASS I Guidelines
- The Living Guidelines: Antiplatelet Agents/Anticoagulants: Warfarin Polling Results for CLASS I Guidelines
- The Living Guidelines: Antiplatelet Agents/Anticoagulants: Warfarin Suggest Revisions to the CLASS I Guidelines
- The Living Guidelines: Antiplatelet Agents/Anticoagulants: Warfarin View the Current CLASS I Guidelines
- The Living Guidelines: Beta Blockers Polling Results for CLASS IIa Guidelines
- The Living Guidelines: Beta Blockers Polling Results for CLASS I Guidelines
- The Living Guidelines: Beta Blockers Suggest Revisions to the CLASS IIa Guidelines
- The Living Guidelines: Beta Blockers Suggest Revisions to the CLASS I Guidelines
- The Living Guidelines: Beta Blockers View the Current CLASS IIa Guidelines
- The Living Guidelines: Beta Blockers View the Current CLASS I Guidelines
- The Living Guidelines: Blood Pressure Control Polling Results for CLASS I Guidelines
- The Living Guidelines: Blood Pressure Control Suggest Revisions to the CLASS I Guidelines
- The Living Guidelines: Blood Pressure Control View the Current CLASS I Guidelines
- The Living Guidelines: Chronic Kidney Disease Polling Results for CLASS I Guidelines
- The Living Guidelines: Chronic Kidney Disease Suggest Revisions to the CLASS I Guidelines
- The Living Guidelines: Chronic Kidney Disease View the Current CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris
- The Living Guidelines: Chronic Stable Angina Pectoris ACE InhibitorsTherapy Polling Results for CLASS III Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris ACE InhibitorsTherapy Polling Results for CLASS IIa Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris ACE InhibitorsTherapy Polling Results for CLASS IIb Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris ACE InhibitorsTherapy Suggest Revisions to the CLASS IIa Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris ACE Inhibitors Therapy Polling Results for CLASS IIa Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris ACE Inhibitors Therapy Polling Results for CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris ACE Inhibitors Therapy Suggest Revisions to the CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris ACE Inhibitors Therapy View the Current CLASS IIa Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris ACE Inhibitors Therapy View the Current CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Aldosterone Blockers Therapy Polling Results for CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Aldosterone Blockers Therapy Suggest Revisions to the CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Aldosterone Blockers Therapy View the Current CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Angiotensin Receptor Blockers Therapy Polling Results for CLASS IIb Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Angiotensin Receptor Blockers Therapy Suggest Revisions to the CLASS IIb Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Angiotensin Receptor Blockers Therapy View the Current CLASS IIb Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Anti lipid Therapy Polling Results for CLASS III Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Anti lipid Therapy Polling Results for CLASS IIa Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Anti lipid Therapy Polling Results for CLASS IIb Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Anti lipid Therapy Polling Results for CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Anti lipid Therapy Suggest Revisions to the CLASS IIa Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Antiplatelet Therapy Polling Results for CLASS III Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Antiplatelet Therapy Polling Results for CLASS IIa Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Antiplatelet Therapy Polling Results for CLASS IIb Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Antiplatelet Therapy Polling Results for CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Antiplatelets/Anticoagulants Therapy Polling Results for CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Antiplatelets/Anticoagulants Therapy Suggest Revisions to the CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Antiplatelets/Anticoagulants Therapy View the Current CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Beneficial Lipid Management Strategies Polling Results for CLASS IIa Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Beneficial Lipid Management Strategies Polling Results for CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Beneficial Lipid Management Strategies Suggest Revisions to the CLASS II Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Beneficial Lipid Management Strategies Suggest Revisions to the CLASS IIa Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Beneficial Lipid Management Strategies View the Current CLASS IIa Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Beneficial Lipid Management Strategies View the Current CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Beta Blocker Therapy Polling Results for CLASS III Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Beta Blocker Therapy Polling Results for CLASS IIa Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Beta Blocker Therapy Polling Results for CLASS IIb Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Beta Blocker Therapy Polling Results for CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Beta Blockers Therapy Polling Results for CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Beta Blockers Therapy Suggest Revisions to the CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Beta Blockers Therapy View the Current CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Calcium Antagonists Therapy Polling Results for CLASS III Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Calcium Antagonists Therapy Polling Results for CLASS IIa Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Calcium Antagonists Therapy Polling Results for CLASS IIb Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Calcium Antagonists Therapy Polling Results for CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris General Considerations for Lipid Management Polling Results for CLASS IIb Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris General Considerations for Lipid Management Polling Results for CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris General Considerations for Lipid Management Suggest Revisions to the CLASS II Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris General Considerations for Lipid Management Suggest Revisions to the CLASS IIb Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris General Considerations for Lipid Management Suggest Revisions to the CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris General Considerations for Lipid Management View the Current CLASS IIa Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris General Considerations for Lipid Management View the Current CLASS IIb Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris General Considerations for Lipid Management View the Current CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Nitrates Polling Results for CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Nitrates Therapy Polling Results for CLASS III Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Nitrates Therapy Polling Results for CLASS IIa Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Nitrates Therapy Polling Results for CLASS IIb Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Recommendations for Blood Pressure Control Polling Results for CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Recommendations for Blood Pressure Control Suggest Revisions to the CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Recommendations for Blood Pressure Control View the Current CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Recommendations for Diabetes Management Polling Results for CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Recommendations for Diabetes Management Suggest Revisions to the CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Recommendations for Diabetes Management View the Current CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Recommendations for LDL-C, HDL-C and Triglycerides Management Polling Results for CLASS IIa Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Recommendations for LDL-C, HDL-C and Triglycerides Management Polling Results for CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Recommendations for LDL-C, HDL-C and Triglycerides Management Suggest Revisions to the CLASS IIa Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Recommendations for LDL-C, HDL-C and Triglycerides Management Suggest Revisions to the CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Recommendations for LDL-C, HDL-C and Triglycerides Management View the Current CLASS IIa Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Recommendations for LDL-C, HDL-C and Triglycerides Management View the Current CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Recommendations for Physical Activity Polling Results for CLASS IIb Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Recommendations for Physical Activity Polling Results for CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Recommendations for Physical Activity Suggest Revisions to the CLASS IIb Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Recommendations for Physical Activity Suggest Revisions to the CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Recommendations for Physical Activity View the Current CLASS IIb Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Recommendations for Physical Activity View the Current CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Recommendations for Smoking Cessation Polling Results for CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Recommendations for Smoking Cessation Suggest Revisions to the CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Recommendations for Smoking Cessation View the Current CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Recommendations for Weight Management Polling Results for CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Recommendations for Weight Management Suggest Revisions to the CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Pectoris Recommendations for Weight Management View the Current CLASS I Guidelines
- The Living Guidelines: Chronic Stable Angina Recommendations for Alternative Therapies Polling Results for CLASS IIa Guidelines
- The Living Guidelines: Chronic Stable Angina Recommendations for Alternative Therapies Polling Results for CLASS IIb Guidelines
- The Living Guidelines: Chronic Stable Angina Recommendations for Revascularization Polling Results for CLASS III Guidelines
- The Living Guidelines: Chronic Stable Angina Recommendations for Revascularization Polling Results for CLASS IIa Guidelines
- The Living Guidelines: Chronic Stable Angina Recommendations for Revascularization Polling Results for CLASS IIb Guidelines
- The Living Guidelines: Chronic Stable Angina Recommendations for Revascularization Polling Results for CLASS I Guidelines
- The Living Guidelines: Diabetes Management Polling Results for CLASS I Guidelines
- The Living Guidelines: Diabetes Management Suggest Revisions to the CLASS I Guidelines
- The Living Guidelines: Diabetes Management View the Current CLASS I Guidelines
- The Living Guidelines: Diagnosis and Management of Atrial Fibrillation
- The Living Guidelines: Diagnosis and Management of Chronic Heart Failure
- The Living Guidelines: Direct-current cardioversion of atrial fibrillation and atrial flutter: Polling Results for CLASS III Guidelines
- The Living Guidelines: Direct-current cardioversion of atrial fibrillation and atrial flutter: Polling Results for CLASS IIa Guidelines
- The Living Guidelines: Direct-current cardioversion of atrial fibrillation and atrial flutter: Polling Results for CLASS I Guidelines
- The Living Guidelines: Direct-current cardioversion of atrial fibrillation and atrial flutter: Suggest Revisions to the CLASS III Guidelines
- The Living Guidelines: Direct-current cardioversion of atrial fibrillation and atrial flutter: Suggest Revisions to the CLASS IIa Guidelines
- The Living Guidelines: Direct-current cardioversion of atrial fibrillation and atrial flutter: Suggest Revisions to the CLASS I Guidelines
- The Living Guidelines: Direct-current cardioversion of atrial fibrillation and atrial flutter: View the Current CLASS III Guidelines
- The Living Guidelines: Direct-current cardioversion of atrial fibrillation and atrial flutter: View the Current CLASS IIa Guidelines
- The Living Guidelines: Direct-current cardioversion of atrial fibrillation and atrial flutter: View the Current CLASS I Guidelines
- The Living Guidelines: Drug Eluting and Bare Metal Stents Polling Results for CLASS IIa Guidelines
- The Living Guidelines: Drug Eluting and Bare Metal Stents Polling Results for CLASS IIb Guidelines
- The Living Guidelines: Drug Eluting and Bare Metal Stents Polling Results for CLASS I Guidelines
- The Living Guidelines: Drug Eluting and Bare Metal Stents Suggest Revisions to the CLASS IIa Guidelines
- The Living Guidelines: Drug Eluting and Bare Metal Stents Suggest Revisions to the CLASS IIb Guidelines
- The Living Guidelines: Drug Eluting and Bare Metal Stents Suggest Revisions to the CLASS I Guidelines
- The Living Guidelines: Drug Eluting and Bare Metal Stents View the Current CLASS IIa Guidelines
- The Living Guidelines: Drug Eluting and Bare Metal Stents View the Current CLASS IIb Guidelines
- The Living Guidelines: Drug Eluting and Bare Metal Stents View the Current CLASS I Guidelines
- The Living Guidelines: End-of-life Considerations. Polling Results for CLASS III Guidelines
- The Living Guidelines: End-of-life Considerations. Polling Results for CLASS I Guidelines
- The Living Guidelines: End-of-life Considerations. Suggest Revisions to the CLASS III Guidelines
- The Living Guidelines: End-of-life Considerations. Suggest Revisions to the CLASS I Guidelines
- The Living Guidelines: End-of-life Considerations. View the Current CLASS III Guidelines
- The Living Guidelines: End-of-life Considerations. View the Current CLASS I Guidelines
- The Living Guidelines: Implementation of Practice Guidelines. Polling Results for CLASS III Guidelines
- The Living Guidelines: Implementation of Practice Guidelines. Polling Results for CLASS IIa Guidelines
- The Living Guidelines: Implementation of Practice Guidelines. Polling Results for CLASS IIb Guidelines
- The Living Guidelines: Implementation of Practice Guidelines. Polling Results for CLASS I Guidelines
- The Living Guidelines: Implementation of Practice Guidelines. Suggest Revisions to the CLASS III Guidelines
- The Living Guidelines: Implementation of Practice Guidelines. Suggest Revisions to the CLASS IIa Guidelines
- The Living Guidelines: Implementation of Practice Guidelines. Suggest Revisions to the CLASS IIb Guidelines
- The Living Guidelines: Implementation of Practice Guidelines. Suggest Revisions to the CLASS I Guidelines
- The Living Guidelines: Implementation of Practice Guidelines. View the Current CLASS III Guidelines
- The Living Guidelines: Implementation of Practice Guidelines. View the Current CLASS IIa Guidelines
- The Living Guidelines: Implementation of Practice Guidelines. View the Current CLASS IIb Guidelines
- The Living Guidelines: Implementation of Practice Guidelines. View the Current CLASS I Guidelines
- The Living Guidelines: Influenza Vaccination Polling Results for CLASS I Guidelines
- The Living Guidelines: Influenza Vaccination Suggest Revisions to the CLASS I Guidelines
- The Living Guidelines: Influenza Vaccination View the Current CLASS I Guidelines
- The Living Guidelines: Initial Clinical Assessment of Patients Presenting with Heart Failure. Polling Results for CLASS III Guidelines
- The Living Guidelines: Initial Clinical Assessment of Patients Presenting with Heart Failure. Polling Results for CLASS IIa Guidelines
- The Living Guidelines: Initial Clinical Assessment of Patients Presenting with Heart Failure. Polling Results for CLASS IIb Guidelines